Skip Navigation

This Article
Right arrow Abstract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (27)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Gong, M.
Right arrow Articles by Hübner, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gong, M.
Right arrow Articles by Hübner, N.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Molecular Genetics, 2003, Vol. 12, No. 11 1273-1277
DOI: 10.1093/hmg/ddg135
© 2003 Oxford University Press

Genome-wide linkage reveals a locus for human essential (primary) hypertension on chromosome 12p

Maolian Gong1,2, Hongye Zhang1, Herbert Schulz2,3, Young-Ae Lee2,4, Kai Sun1, Sylvia Bähring2,5, Friedrich C. Luft2,5, Peter Nürnberg2,6, André Reis2,7, Klaus Rohde2, Detlev Ganten2,3, Rutai Hui1 and Norbert Hübner2,3,*

1Cardiovascular Institute, Sino-German Laboratory, FuWai Hospital, Beijing, People's Republic of China, 2Max-Delbrück-Center for Molecular Medicine (MDC), Berlin-Buch, Germany, 3Department of Clinical Pharmacology, Freie University, Berlin, Germany, 4Department of Pediatric Pneumology and Immunology, Charité, Humboldt-University Berlin, Germany, 5Franz Volhard Clinic, HELIOS-Klinikum, Charité, Humboldt-University Berlin, Germany, 6Institute of Medical Genetics, Charité, Humboldt-University Berlin, Germany and 7Department of Human Genetics, Friedrich-Alexander University, Erlangen, Germany

Received January 13, 2003; Revised March 4, 2003; Accepted March 21, 2003


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 RESULTS
 DISCUSSION
 METHODS
 REFERENCES
 
Essential (primary) hypertension is an important risk factor for cardiovascular morbidity and mortality. Blood pressure is largely heritable; however, the genetic factors contributing to essential hypertension are mostly unknown. We examined a large Chinese kindred (n=387) and selected a subset of 94 individuals for genotyping. An additional 32 Chinese nuclear families with essential hypertension were also recruited. Genome-wide parametric linkage analysis identified a new locus for primary hypertension on chromosome 12p (parametric LOD score 3.44). This locus overlaps with the assigned locus that causes severe autosomal-dominant hypertension and brachydactyly, the only form of monogenic hypertension known to date that resembles primary hypertension. We suggest that this genomic region, spanning 18 annotated genes, will be of great relevance in elucidating new mechanisms for primary hypertension.


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 RESULTS
 DISCUSSION
 METHODS
 REFERENCES
 
Death and disability from cardiovascular disease is increasing rapidly in all countries so that cardiovascular disease will still be the commonest cause of death worldwide early in this century (1,2). Arterial hypertension is a major risk factor for stroke and myocardial infarction (3). Although hypertension may be secondary, most (>95%) hypertension is ‘essential’ or primary. Primary hypertension, which affects about 20% of adults, is partly genetically determined; the estimates on genetic variance range from 20 to 50% (47).

Epidemiological data suggest that there is a remarkable difference in the level of blood pressure and the geographic regions in China with a prevalence of hypertension ranging from as low as 3% to more than 20% (8). Comparison of epidemiological blood pressure data is difficult due to subtle but important differences in the circumstances and techniques used for blood pressure measurements. However, there is epidemiological evidence that the age-specific prevalence of hypertension in China is lower compared with westernized countries but similar to other developing countries (810). The prevalence of secondary hypertension in Chinese communities was reported to be slightly higher than 1% (11).

Primary hypertension is extremely heterogeneous and the genetic contributions remain largely unknown (12). Several studies have investigated linkage and/or association of candidate genes in primary hypertension but most do not appear to contribute to primary hypertension. Only two contribution of two candidates—the angiotensinogen gene on chromosome 1 and the alpha adducin gene on chromosome 4—have held up in multiple studies (13). There have been several genome-wide linkage scans of familial blood pressure distribution/variation (1420) and for essential hypertension (2124), most of them not attaining significance at a genome-wide level. One possible approach to the problem of the tremendous genetic heterogeneity associated with primary hypertension is the ascertainment of hypertensive pedigrees from relatively isolated populations. We pursued such a strategy and recruited hypertensive pedigrees from a relatively isolated rural region in China (Table 1). Here, we report significant linkage to chromosome 12p in our genome-wide linkage study in a large Chinese kindred and additional nuclear families.


View this table:
[in this window]
[in a new window]
 
Table 1. Basic phenotype characteristics of the study population
 

    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 RESULTS
 DISCUSSION
 METHODS
 REFERENCES
 
A maximum multipoint LOD score of 2.82 was obtained at marker D12S1682. With the 16 additional markers, a multipoint linkage analysis revealed a maximum parametric LOD score of 2.85. To expand on these findings, we recruited 32 nuclear families (parents and offspring) with essential hypertension, n=5.4 per family totaling 174 individuals from the Shijingshan district. Parametric linkage analysis revealed a significant effect of chromosome 12 on blood pressure when the two subsets were combined (parametric LOD score 3.44; Fig. 1). These findings strongly support the presence of a major hypertension gene within this chromosomal segment.



View larger version (15K):
[in this window]
[in a new window]
 
Figure 1. Parametric multipoint linkage results of chromosome 12p. The multipoint LOD score is on the vertical axis and centimorgan distances from the p-terminus of the chromosome is on the horizontal axis. The marker information content is plotted across the region. The horizontal dotted line represents the significance threshold according to Lander and Kruglyak (39).

 
All individuals classified as hypertensive consistently had elevated systolic and diastolic blood pressure levels. Thus, no reclassification according to systolic or diastolic blood pressure was necessary. The observed linkage on chromosome 12p holds for both systolic and diastolic blood pressure levels.

We were surprised to find a nearly perfect overlap with a previously identified monogenic high blood pressure locus detected in a Turkish family with severe autosomal hypertension and brachydactyly as shown in Figure 2 (2527). This monogenic hypertension resembles primary hypertension since the renin-angiotensin system is normal and affected persons are not salt-sensitive (28). None of our subjects have brachydactyly. However, the syndrome in the Turkish subjects may be a contiguous gene syndrome and the brachydactyly may not necessarily be caused by the same gene generating the increased blood pressure.



View larger version (20K):
[in this window]
[in a new window]
 
Figure 2. Representation of the region linked to essential hypertension in this report and the previously reported linkage to hypertension in a Turkish family with brachydactyly (2123).

 

    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 RESULTS
 DISCUSSION
 METHODS
 REFERENCES
 
Possibly, ‘less dramatic’ molecular variants of genes causing severe forms of monogenic hypertension contribute to the far more common, primary hypertension. However, evidence to support this notion is scanty. Our findings demonstrating linkage to primary hypertension in Chinese to chromosome 12p, coupled with the fact that severe autosomal-dominant hypertension in the Turkish kindred resembles primary hypertension, strongly suggests that the identification of responsible gene(s) within this genomic region will be generally relevant. The locus has been cloned and sequenced in its entirety (29,30) providing a list of annotated positional candidate genes across this region. Furthermore, single-nucleotide polymorphisms (SNPs) are available for systematic approaches to define the disease-associated mutation(s) (see Ensembl and Celera databases at www.ensembl.org and www.celera.com).

Two candidate genes reside on chromosome 12p that may play an important role in the maintenance of vascular function and blood pressure. PDE3A is a cyclic nucleotide phosphodiesterase whose physiological role is the attenuation of the signaling mediated by the ubiquitous second messangers cAMP and cGMP (31). PDE3A and PDE3B both interact with the renin–angiotensin system. The renin–angiotensin system is important in controlling blood pressure, maintaining electrolyte and volume homeostasis, and regulating renal autoregulation (32). Another candidate of equal interest encodes the sulfonylurea receptor ABCC9 (SUR2). Sulfonylurea receptors represent one of four subunits in the assembly of ATP-sensitive potassium channels. The activity of this channel can be altered by a diverse group of drugs, so-called potassium channel openers. These drugs may have utility in lowering blood pressure (33).

Linkage was not detected in any other region of the genome. This might have been due to the limited power of our study, which was determined to be 58.7 and 20.4% for suggestive and significant linkage, respectively. It may be that the current cohort was not sufficiently large to identify additional or previously reported loci of small or moderate effect.

We provide strong evidence for a susceptibility locus on chromosome 12p. Although the locus was identified in Chinese families from a relatively isolated rural region, the overlap with a Mendelian form of hypertension with brachydactyly in a Turkish kindred suggests that lesser variants of the same gene might contribute to primary hypertension.

The data presented here make this genomic region amenable for dense association scans in positional candidates. We suggest that susceptibility gene(s) for essential hypertension may reside on chromosome 12p.


    METHODS
 TOP
 ABSTRACT
 INTRODUCTION
 RESULTS
 DISCUSSION
 METHODS
 REFERENCES
 
We ascertained an extended pedigree with information from 387 members over seven generations from a rural village from Shijingshan, China (34). Hypertension occurs in 24%. Blood pressure measurements from all family members were obtained several times over a 2–5 year period. Blood pressure was measured with a mercury sphygmomanometer in seated subjects after 5 min rest. Three measurements were obtained 1 min apart and the values averaged. Subjects with values >140/90 mmHg (below age 35 years) or >160/95 mmHg (above age 35 years) were defined as hypertensive. Individuals prescribed antihypertensive drugs were also defined as hypertensive (Table 1). However, since longitudinal blood pressure measurements were ascertained, extensive and unambiguous documentation of pretreatment hypertensive values were available. None of the individuals while being treated with antihypertensive drugs had normotensive blood pressure values below 140/90 mmHg.

Ten adult hypertensive family members from both genders aged 34–75 were randomly selected from the large pedigree. These persons underwent extensive clinical investigations to exclude any causes of secondary or known monogenic forms of hypertension (12) (data not shown). Ninety-four family members were selected according their availability for genetic analysis (48 affected and 46 non-affected). Additionally we recruited 32 nuclear families (parents and offspring with essential hypertension totaling 174 individuals; n=5.4 per family), according to the same criteria as described above. After informed consent, blood was obtained for DNA extraction. Again 10 hypertensive individuals were randomly selected to exclude secondary hypertension.

A genome-wide linkage analysis using 387 polymorphic microsatellite markers was performed. We carried out fluorescence-based semi-automated genotyping using 387 autosomal microsatellite markers from the Généthon linkage map (35) with an average heterozygosity of 0.8. We typed 16 additional markers on chromosome 12 where linkage was detected. After individual PCR amplification, products were pooled and size-fractionated by electrophoresis on MegaBase 1000 (Amersham Pharmacia) or ABI 3100 (Applied Biosystems) DNA capillary sequencers.

Individual markers were completely typed on one genotyping station. We determined allele sizes using the GeneticProfiler (Amersham Pharmacia) or Genescan 2.1.1. and Genotyper V2 software (Applied Biosystems). All marker genotypes were checked for Mendelian inheritance using the PedCheck software (36). Parametric linkage analysis was performed with Genehunter V2.1 (37) using marker distances according to the Généthon linkage map (35) and uniform allele frequencies. A dominant (0.02, 0.7, 0.7) inheritance model and a disease allele frequency of 0.14 were assumed. For linkage analysis, we divided the entire large pedigree down to eight smaller branches because of computational constraints. Statistical power calculations were performed with Allegro (38) simulating 1000 genome-wide replicates with the same specifications that were used in the subsequent final analysis. The power of this study was determined to be 58.7 and 20.4% to detect suggestive and significant linkage, respectively.


    ACKNOWLEDGEMENTS
 
We thank Dr Liu Lisheng and Dr Thomas F. Wienker for helpful advice and discussion. This study was partly supported by a Sino-German bi-national grant-in-aid from the German Bundesministerium für Bildung und Forschung (BMBF), from the International Office for Asian–German relations, by the Science and Technology Commission of Beijing, and the Natural Science Foundation of China. S.B. and F.C.L. received support from the Deutsche Forschungsgemeinschaft and EurNetGen.


    FOOTNOTES
 
* To whom correspondence should be addressed at: Max-Delbrück-Center for Molecular Medicine (MDC), Robert-Rössle-Str. 10, 13092 Berlin, Germany. Tel: +49 3094062530; Fax: +49 3094062110; Email: nhuebner{at}mdc-berlin.de Back


    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 RESULTS
 DISCUSSION
 METHODS
 REFERENCES
 

  1. Lopez, A.D. and Murray, C.C. (1998) The global burden of disease, 1990–2020. Nat. Med., 4, 1241–1243.[CrossRef][Web of Science][Medline]

  2. World Health Organization–International Society of Hypertension (1999) 1999 World Health Organization–International Society of Hypertension Guidelines for the Management of Hypertension, Guidelines Subcommittee. J. Hypertens., 17, 151–183.[Web of Science][Medline]

  3. The Sixth Report of the Joint National Committee (1997) The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch. Intern. Med., 157, 2413–2446.[Abstract/Free Full Text]

  4. Longini, I.M., Jr., Higgins, M.W., Hinton, P.C., Moll, P.P. and Keller, J.B. (1984) Environmental and genetic sources of familial aggregation of blood pressure in Tecumseh, Michigan. Am. J. Epidemiol., 120, 131–144.[Abstract/Free Full Text]

  5. Hunt, S.C., Hasstedt, S.J., Kuida, H., Stults, B.M., Hopkins, P.N. and Williams, R.R. (1989) Genetic heritability and common environmental components of resting and stressed blood pressures, lipids, and body mass index in Utah pedigrees and twins. Am. J. Epidemiol., 129, 625–638.[Abstract/Free Full Text]

  6. Rice, T., Vogler, G.P., Perusse, L., Bouchard, C. and Rao, D.C. (1989) Cardiovascular risk factors in a French Canadian population: resolution of genetic and familial environmental effects on blood pressure using twins, adoptees, and extensive information on environmental correlates. Genet. Epidemiol., 6, 571–588.[CrossRef][Web of Science][Medline]

  7. Perusse, L., Moll, P.P. and Sing, C.F. (1991) Evidence that a single gene with gender- and age-dependent effects influences systolic blood pressure determination in a population-based sample. Am. J. Hum. Genet., 49, 94–105.[Medline]

  8. Ueshima, H., Zhang, X.H. and Choudhury, S.R. (2000) Epidemiology of hypertension in China and Japan. J. Hum. Hypertens., 14, 765–769.[CrossRef][Web of Science][Medline]

  9. Swales, J.D. (ed.) (1994) Textbook of Hypertension. Blackwell Scientific, Oxford, pp. 11–36.

  10. Gu, D., Reynolds, K., Wu, X., Chen, J., Duan, X., Muntner, P., Huang, G., Reynolds, R.F., Su, S. and Whelton, P.K., He, J. (2002) Prevalence, awareness, treatment, and control of hypertension in China. Hypertension, 40, 920–927.[Abstract/Free Full Text]

  11. Lisheng, L., Jinxiang, X., Shouqi, T., Lu, J., Xiue, Z. and Yueqiu, S. (1980) Secondary hypertension in the community and among hospitalized hypertensive patients. Acta Acad. Med. Sin., 2, 238–240.

  12. Lifton, R.P., Gharavi, A.G. and Geller, D.S. (2001) Molecular mechanisms of human hypertension. Cell, 104, 545–556.[CrossRef][Web of Science][Medline]

  13. Cusi, D. and Bianchi, G. (1998) A primer on the genetics of hypertension. Kidney. Int., 54, 328–342.[CrossRef][Web of Science][Medline]

  14. Atwood, L.D., Samollow, P.B., Hixson, J.E., Stern, M.P. and MacCluer, J.W. (2001) Genome-wide linkage analysis of blood pressure in Mexican Americans. Genet. Epidemiol., 20, 373–382.[CrossRef][Web of Science][Medline]

  15. Hsueh, W.C., Mitchell, B.D., Schneider, J.L., Wagner, M.J., Bell, C.J., Nanthakumar, E. and Shuldiner, A.R. (2000) QTL influencing blood pressure maps to the region of PPH1 on chromosome 2q31–34 in Old Order Amish. Circulation, 20, 2810–2816.

  16. Levy, D., DeStefano, A.L., Larson, M.G., O'Donnell, C.J., Lifton, R.P., Gavras, H., Cupples, L.A. and Myers, R.H. (2000) Evidence for a gene influencing blood pressure on chromosome 17. Genome scan linkage results for longitudinal blood pressure phenotypes in subjects from the framingham heart study. Hypertension, 36, 477–483.[Abstract/Free Full Text]

  17. Pankow, J.S., Rose, K.M., Oberman, A., Hunt, S.C., Atwood, L.D., Djousse, L., Province, M.A. and Rao, D.C. (2000) Possible locus on chromosome 18q influencing postural systolic blood pressure changes. Hypertension, 36, 471–476.[Abstract/Free Full Text]

  18. Rice, T., Rankinen, T., Province, M.A., Chagnon, Y.C., Perusse, L., Borecki, I.B., Bouchard, C. and Rao, D.C. (2000) Genomewide linkage analysis of systolic and diastolic blood pressure: the Quebec Family Study. Circulation, 102, 1956–1963.[Abstract/Free Full Text]

  19. Krushkal, J., Ferrell, R., Mockrin, S.C., Turner, S.T., Sing, C.F. and Boerwinkle, E. (1999) Genome-wide linkage analyses of systolic blood pressure using highly discordant siblings. Circulation, 23, 1407–1410.

  20. Xu, X., Rogus, J.J., Terwedow, H.A., Yang, J., Wang, Z., Chen, C., Niu, T., Wang, B., Xu, H., Weiss, S., Schork, N.J. and Fang, Z. (1999) An extreme-sib-pair genome scan for genes regulating blood pressure. Am. J. Hum. Genet., 64, 1694–1701.[CrossRef][Web of Science][Medline]

  21. Zhu, D.L., Wang, H.Y., Xiong, M.M., He, X., Chu, S.L., Jin, L., Wang, G.L., Yuan, W.T., Zhao, G.S., Boerwinkle, E. and Huang, W. (2001) Linkage of hypertension to chromosome 2q14–q23 in Chinese families. J. Hypertens., 19, 55–61.[CrossRef][Web of Science][Medline]

  22. Perola, M., Kainulainen, K., Pajukanta, P., Terwilliger, J.D., Hiekkalinna, T., Ellonen, P., Kaprio, J., Koskenvuo, M., Kontula, K. and Peltonen, L. (2000) Genome-wide scan of predisposing loci for increased diastolic blood pressure in Finnish siblings. J. Hypertens., 18, 1579–1585.[CrossRef][Web of Science][Medline]

  23. Sharma, P., Fatibene, J., Ferraro, F., Jia, H., Monteith, S., Brown, C., Clayton, D., O'Shaughnessy, K. and Brown, M.J. (2000) A genome-wide search for susceptibility loci to human essential hypertension. Hypertension, 35, 1291–1296.[Abstract/Free Full Text]

  24. Kristjansson, K., Manoöescu, A., Kristinsson, A., Hardarson, T., Knudsen, H., Ingason, S., Thorleifsson, G., Frigge, M.L., Kong, A., Gulcher, J.R. and Stefansson, K. (2002) Linkage of essential hypertension to chromosome 18q. Hypertension, 39, 1044–1049.[Abstract/Free Full Text]

  25. Schuster, H., Wienker, T.E., Bahring, S., Bilginturan, N., Toka, H.R., Neitzel, H., Jeschke, E., Toka, O., Gilbert, D., Lowe, A. et al. (1996) Severe autosomal dominant hypertension and brachydactyly in a unique Turkish kindred maps to human chromosome 12. Nat. Genet., 13, 98–100.[CrossRef][Web of Science][Medline]

  26. Bahring, S., Nagai, T., Toka, H.R., Nitz, I., Toka, O., Aydin, A., Muhl, A., Wienker, T.F., Schuster, H. and Luft, F.C. (1997) Deletion at 12p in a Japanese child with brachydactyly overlaps the assigned locus of brachydactyly with hypertension in a Turkish family. Am. J. Hum. Genet., 60, 732–735.[Web of Science][Medline]

  27. Toka, H.R., Bahring, S., Chitayat, D., Melby, J.C., Whitehead, R., Jeschke, E., Wienker, T.F., Toka, O., Schuster, H. and Luft, F.C. (1998) Families with autosomal dominant brachydactyly type E, short stature, and severe hypertension. Ann. Intern. Med., 129, 204–208.[Abstract/Free Full Text]

  28. Schuster, H., Wienker, T.F., Toka, H.R., Bahring, S., Jeschke, E., Toka, O., Busjahn, A., Hempel, A., Tahlhammer, C. et al. (1996) Autosomal dominant hypertension and brachydactyly in a Turkish kindred resembles essential hypertension. Hypertension, 28, 1085–1092.[Abstract/Free Full Text]

  29. Lander, E.S., Linton, L.M., Birren, B., Nusbaum, C., Zody, M.C., Baldwin, J., Devon, K. et al. (2001) Initial sequencing and analysis of the human genome. Nature, 409, 860–921.[CrossRef][Medline]

  30. Venter, J.C., Adams, M.D., Myers, E.W., Li, P.W., Mural, R.J., Sutton, G.G., Smith, H.O. et al. (2001) The sequence of the human genome. Science, 291, 1304–1351.[Abstract/Free Full Text]

  31. Beavo, J.A. (1995) Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. Physiol. Rev., 75, 725–748.[Abstract/Free Full Text]

  32. Friis, U.G., Jensen, B.L., Sethi, S., Andreasen, D., Hansen, P.B. and Skott,O. (2002) Control of renin secretion from rat juxtaglomerular cells by cAMP- specific phosphodiesterases. Circul. Res., 90, 996–1003.[Abstract/Free Full Text]

  33. Lawson, K. (1996) Potassium channel activation: a potential therapeutic approach? Pharmac. Ther., 70, 39–63.[CrossRef][Web of Science][Medline]

  34. Tao, S. and Zhou, B. (1999) Epidemiology of hypertension in China. Chin. Med. J. (Engl.), 112, 878–882.[Medline]

  35. Dib, C., Faure, S., Fizames, C., Samson, D., Drouot, N., Vignal, A., Millasseau, P., Marc, S., Hazan, J., Seboun, E. et al. (1996) A comprehensive genetic map of the human genome based on 5,264 microsatellites. Nature, 380, 152–154.[CrossRef][Medline]

  36. O'Connell, J.R. and Weeks, D.E. (1998) PedCheck: a program for identification of genotype incompatibilities in linkage analysis. Am. J. Hum. Genet., 63, 259–266.[CrossRef][Web of Science][Medline]

  37. Markianos, K., Daly, M.J. and Kruglyak, L. (2001) Efficient multipoint linkage analysis through reduction of inheritance space. Am. J. Hum. Genet., 68, 963–977.[CrossRef][Web of Science][Medline]

  38. Gudbjartsson, D.F., Jonasson, K., Frigge, M.L. and Kong, A. (2000) Allegro, a new computer program for multipoint linkage analysis. Nat. Genet., 25, 12–13.[CrossRef][Web of Science][Medline]

  39. Lander, E.S. and Kruglyak, L. (1995) Genetic dissection of complex traits: guideline for interpreting and reporting linkage results. Nat. Genet., 11, 241–247.[CrossRef][Web of Science][Medline]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
HypertensionHome page
G. Shi, C. C. Gu, A. T. Kraja, D. K. Arnett, R. H. Myers, J. S. Pankow, S. C. Hunt, and D. C. Rao
Genetic Effect on Blood Pressure Is Modulated by Age: The Hypertension Genetic Epidemiology Network Study
Hypertension, January 1, 2009; 53(1): 35 - 41.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
S. Bahring, M. Kann, Y. Neuenfeld, M. Gong, D. Chitayat, H. R. Toka, O. Toka, G. Plessis, P. Maass, A. Rauch, et al.
Inversion Region for Hypertension and Brachydactyly on Chromosome 12p Features Multiple Splicing and Noncoding RNA
Hypertension, February 1, 2008; 51(2): 426 - 431.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
C. Hadtstein and F. Schaefer
What adult nephrologists should know about childhood blood pressure
Nephrol. Dial. Transplant., August 1, 2007; 22(8): 2119 - 2123.
[Full Text] [PDF]


Home page
HypertensionHome page
A. F. Dominiczak, D. Graham, M. W. McBride, N. J.R. Brain, W. K. Lee, F. J. Charchar, M. Tomaszewski, C. Delles, and C. A. Hamilton
Cardiovascular Genomics and Oxidative Stress
Hypertension, April 1, 2005; 45(4): 636 - 642.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
D. S. Geller
A Genetic Predisposition to Hypertension?
Hypertension, July 1, 2004; 44(1): 27 - 28.
[Full Text] [PDF]


Home page
Hum Mol GenetHome page
C. A. Mein, M. J. Caulfield, R. J. Dobson, and P. B. Munroe
Genetics of essential hypertension
Hum. Mol. Genet., April 1, 2004; 13(90001): R169 - 175.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
S. Bahring, A. Rauch, O. Toka, C. Schroeder, C. Hesse, H. Siedler, G. Fesus, W. E. Haefeli, A. Busjahn, A. Aydin, et al.
Autosomal-Dominant Hypertension With Type E Brachydactyly Is Caused by Rearrangement on the Short Arm of Chromosome 12
Hypertension, February 1, 2004; 43(2): 471 - 476.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
F. C. Luft, O. Toka, H. R. Toka, J. Jordan, and S. Bahring
Mendelian hypertension with brachydactyly as a molecular genetic lesson in regulatory physiology
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2003; 285(4): R709 - R714.
[Abstract] [Full Text] [PDF]


Home page
Clin Med ResHome page
F. C. Luft
Mendelian Forms of Human Hypertension and Mechanisms of Disease
Clin. Med. Res., October 1, 2003; 1(4): 291 - 300.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (27)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Gong, M.
Right arrow Articles by Hübner, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gong, M.
Right arrow Articles by Hübner, N.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?